Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYRevista da Associacao Medica Brasileira (1992)

Fundus camera and artificial intelligence for diabetic retinopathy screening in a São Paulo shelter.

  1. 1Irmandade da Santa Casa de Misericórdia de São Paulo - São Paulo (SP), Brazil.
  2. 2Irmandade da Santa Casa de Misericórdia de São Paulo, Department of Ophthalmology - São Paulo (SP), Brazil.

Abstract

Objective

The aim of this study was to evaluate the applicability of a smartphone-based portable fundus camera for diabetic retinopathy screening in elderly residents of a specialized shelter in São Paulo, Brazil, considering image acquisition by non-ophthalmologist professionals and remote case classification.Methods

Prospective pilot interventional study at the Centro de Acolhida Especial para Idosos Morada São João. Thirty-eight participants (76 eyes) underwent retinal imaging using the Eyer® portable fundus camera (Phelcom Technologies, Brazil) by trained non-ophthalmologist professionals. Images were remotely evaluated by a retinal specialist and compared to the EyerMaps® artificial intelligence system.Results

Mean age was 71.6±7.0 years; 78.9% male. Fifteen participants (39.5%) had confirmed diabetes mellitus. The specialist identified abnormalities in 70 of 76 eyes (92.1%), most frequently glaucoma suspicion, media opacity suggestive of cataract, chorioretinal changes, and age-related macular degeneration signs; no diabetic retinopathy was identified. Against the specialist's assessment of any ocular abnormality as the reference standard, the artificial intelligence system classified 22 eyes as abnormal, yielding sensitivity 25.7% (95%CI 16.9-37.0), specificity 33.3% (95%CI 9.7-70.0), positive predictive value 81.8% (95%CI 61.5-92.7), negative predictive value 3.7% (95%CI 1.0-12.5), and overall accuracy 26.3% (95%CI 17.7-37.2).Conclusion

The Eyer® device demonstrated operational feasibility for ocular screening by trained non-ophthalmologists. The high prevalence of media opacities and non-diabetic retinopathy conditions compromised artificial intelligence performance, highlighting the need for broader screening strategies in elderly and socially vulnerable populations.

Related

  1. Artificial intelligence-supported diabetic retinopathy screening in Tanzania: a randomised controlled trial
    Charles R Cleland, Covadonga Bascaran, William U Makupa +16
    The Lancet Global HealthPeer-reviewedCC BY 4.0Medical imaging & radiologyCrossref
  2. Clinical setting-dependent diagnostic accuracy of artificial intelligence and store-and-forward diabetic retinopathy screening: a systematic review and meta-analysis
    Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan
    npj Digital MedicinePeer-reviewedCC BY12 citedMedical imaging & radiologyOpenAlex
  3. Performance Assessment of an Artificial Intelligence System Used for Case Detection in a Large Community-based Diabetic Retinopathy Screening Program: A Retrospective Diagnostic Accuracy Validation Study.
    Maria Kristina Dg Eduardo, Junn R Pajarillo
    Acta medica PhilippinaPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  4. A Robust and Trustable Approach to Incorporate Medical Domain Knowledge in Machine Learning Models for Diabetic Retinopathy Screening Using Routine Lab Results
    Enrico Laoh, Oday Bani Ahmad, Tieming Liu
    Smart health (Amsterdam, Netherlands)Peer-reviewedLicence not statedFull text1 citedMedical imaging & radiologyPMC
  5. ACCESS2 study: the potential for autonomous AI to mitigate disparities in diabetic retinopathy screening in youth
    Risa M. Wolf, Roomasa Channa, T. Y. Alvin Liu +10
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyCrossref
BibTeX
@article{dias2026fundus,
  title = {{Fundus camera and artificial intelligence for diabetic retinopathy screening in a São Paulo shelter.}},
  author = {Julia Gimenes da Silva Dias and Gabriel Costa de Andrade and João Victor Tenório Lossio de Macedo and Andrezza Soldera Graziano},
  journal = {Revista da Associacao Medica Brasileira (1992)},
  year = {2026},
  month = oct,
  doi = {10.1590/1806-9282.20260862},
  url = {https://europepmc.org/article/MED/42912071},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Fundus camera and artificial intelligence for diabetic retinopathy screening in a São Paulo shelter.
AU  - Julia Gimenes da Silva Dias
AU  - Gabriel Costa de Andrade
AU  - João Victor Tenório Lossio de Macedo
AU  - Andrezza Soldera Graziano
PY  - 2026
DA  - 2026/10/16
JO  - Revista da Associacao Medica Brasileira (1992)
DO  - 10.1590/1806-9282.20260862
UR  - https://europepmc.org/article/MED/42912071
AB  - Objective  The aim of this study was to evaluate the applicability of a smartphone-based portable fundus camera for diabetic retinopathy screening in elderly residents of a specialized shelter in São Paulo, Brazil, considering image acquisition by non-ophthalmologist professionals and remote case classification.Methods  Prospective pilot interventional study at the Centro de Acolhida Especial para Idosos Morada São João. Thirty-eight participants (76 eyes) underwent retinal imaging using the Eyer® portable fundus camera (Phelcom Technologies, Brazil) by trained non-ophthalmologist professionals. Images were remotely evaluated by a retinal specialist and compared to the EyerMaps® artificial intelligence system.Results  Mean age was 71.6±7.0 years; 78.9% male. Fifteen participants (39.5%) had confirmed diabetes mellitus. The specialist identified abnormalities in 70 of 76 eyes (92.1%), most frequently glaucoma suspicion, media opacity suggestive of cataract, chorioretinal changes, and age-related macular degeneration signs; no diabetic retinopathy was identified. Against the specialist's assessment of any ocular abnormality as the reference standard, the artificial intelligence system classified 22 eyes as abnormal, yielding sensitivity 25.7% (95%CI 16.9-37.0), specificity 33.3% (95%CI 9.7-70.0), positive predictive value 81.8% (95%CI 61.5-92.7), negative predictive value 3.7% (95%CI 1.0-12.5), and overall accuracy 26.3% (95%CI 17.7-37.2).Conclusion  The Eyer® device demonstrated operational feasibility for ocular screening by trained non-ophthalmologists. The high prevalence of media opacities and non-diabetic retinopathy conditions compromised artificial intelligence performance, highlighting the need for broader screening strategies in elderly and socially vulnerable populations.
SN  - 0104-4230
SN  - 1806-9282
ER  -